Thursday, 14 May 2026

Top of the morning

• Beijing: the Trump–Xi summit is live — opening tone warm, substance still to come

  The summit opened this morning at the Great Hall of the People. Xi framed the meeting around the line that the world is watching and told Trump the two countries are partners rather than rivals; Trump said relations would be better than ever and, per the FT, pressed Xi to open China further to US business. Bloomberg's Businessweek read is the structural caveat: Trump has arrived with CEOs in tow, but it is Xi who holds the leverage, and the Iran war is pulling US attention away from the core agenda of trade, technology and Taiwan. Markets are treating day one as a stability exercise — equities wavered intraday but US futures firmed. The deliverables to watch are economic first (purchases, market access, rare earths), with the more sensitive files — Taiwan arms, any signal on Chinese purchases of Iranian crude — likely held for the Friday working lunch. Eric Trump joined the trip alongside a family-linked group chasing a China deal, a detail the FT flagged as a conflict-of-interest thread.
• Warsh confirmed as Fed chair in the narrowest vote in the institution's history

  The Senate confirmed Kevin Warsh to succeed Jerome Powell, whose term ends tomorrow. The margin was the slimmest ever recorded for a Fed chair, which itself is the signal: the most contested leadership transition at the US central bank in decades begins with the institution's independence already a live political question. The bond market gave its own verdict the same day — Treasury sold 30-year paper at a 5% yield for the first time since 2007, a clean read on how much term premium the fiscal-and-Fed-politics mix is now carrying. For Luca's rates exposure the front end and the long end are telling different stories: cuts still plausibly on the table for the summer, but the long bond is repricing the credibility discount. Lagarde, separately, called this a make-or-break moment to reform the EU, and the ECB's Lane laid out the factors that will drive the next move.
• UK: Starmer prepares to fight as Streeting readies a leadership challenge

  The contest is now explicit. Wes Streeting is preparing to resign and challenge for the leadership; Starmer is preparing to fight rather than step aside. The FT's editorial board framed it as a battle for the soul of Labour and a perilous moment for the UK's standing; Bloomberg's column reads Starmer's most likely usurpers as deeply flawed. The market tell is the cleanest part: UK borrowing costs surged and gilts sold off as the leadership crisis rattled the bond market, and sterling slipped to around 1.35. The FT's "who do gilt investors want to lead Britain" piece is the read on what the bond desk is actually pricing — orderly transition versus drift. Today's UK Q1 flash GDP at 08:00 CET lands directly into this, and Janan Ganesh's column arguing Badenoch is underpriced to become PM is the longer-arc signal.
• Hormuz week twelve: oil back above $100, EIA confirms a near-30% flow hit

  Crude trades around $101.6 with the strait disruption now in its twelfth week. The EIA confirmed Hormuz oil flows fell nearly 30% last quarter — the first hard official number on the scale of the loss. The operational picture stays tense: a Japanese crude tanker made a rare transit outside Hormuz, and a Chinese tanker is reportedly set to test the US naval blockade, a deliberate escalation point. The FT reports Saudi Arabia launched strikes against Iran, and the UAE denied Netanyahu made a secret visit during the conflict. The IEA warned of further price spikes as oil inventories plunge, and Saudi Aramco repeated its warning that fuel stocks are heading toward critically low levels. Hedge funds are betting on biofuels to profit from the shock. The trade structure is unchanged from earlier in the week: refining-margin pain shorter-dated, integrated-major pain longer, and the summer-driving-season demand assumption still un-repriced.
• Cerebras lands the year's biggest IPO; Arm and SoftBank tried to buy it at the eleventh hour

  AI chipmaker Cerebras raised $5.55bn in the largest IPO of 2026, after boosting its price range — and Bloomberg reports Arm and SoftBank attempted a last-minute acquisition before the listing went ahead. The FT's Lex calls it Cerebras joining OpenAI's inner circle, "for a price." This sits inside a broader composition story: US equities hit fresh all-time highs on a tech boost, Alphabet is going global on debt to fund the AI race in volumes that left bankers scrambling, and Musk's xAI is racing to get Wall Street firms onto Grok. The counter-tells matter for the AI-leadership thesis: the FT notes China's big tech groups are missing out on the AI stock-market frenzy entirely, and Europe's few AI plays are soaring precisely because the pool of investable names is so thin. Anduril, separately, doubled its valuation to over $60bn — the defence-tech leg of the same capital wave.
• Asia overnight: Korea's mania cools, Japan duration holds, Bessent offers yen "understanding"

  The standout Asia story remains Korea, where Bloomberg describes the world's biggest stock rally igniting a speculative mania — the Kospi notched a fresh record before sliding more than 2% mid-week as the AI-tax overhang and froth concerns bit. Japan's 30-year bond sale drew demand stronger than the 12-month average, confirming domestic real money is comfortable adding duration even with the BOJ's June-hike signal in the price; Tokyo also said Treasury Secretary Bessent offered "understanding" on yen policy, the diplomatic cover for keeping the currency from breaking 150 through the summit window. Copper retreated from its record close as Chinese buying slowed, and Shanghai opened softer. India is the weak link: private equity is cooling on India amid lofty prices and economic jitters, echoing the foreign-investor exit theme. Japan's Q1 flash GDP printed overnight and feeds the European morning read.
• European session: defence consolidation, AI scarcity premium, gilt stress

  Three threads frame the European open. First, defence: Czech arms group CSG has bid for a stake in Franco-German tank maker KNDS, testing Berlin and Paris on industry consolidation, while Germany is in a fresh push to buy Tomahawks despite the Merz–Trump row and Ukraine nears a deal with the Pentagon to test drones in the US — European defence procurement stays the cleanest structural call in the equity complex. Second, the AI scarcity premium: with so few investable European AI names, the ones that exist are soaring as the US frenzy goes global. Third, the gilt stress from the Starmer crisis is the risk anchor for the session, with UK Q1 flash GDP at 08:00 the data catalyst. Around the tape: Intertek set to agree a £10.6bn EQT takeover, JPMorgan reshuffled its investment-bank chiefs, and Vistry shares plunged as discounted house sales eroded profit.
• FX & commodities: dollar firm, gold eases off the highs, oil bid, copper off its record

  EUR/USD slipped to 1.17 and GBP/USD to 1.35 on the live Bloomberg tape — the dollar firmed modestly, with sterling carrying the UK political discount. Gold eased to $4,681.90, down about half a percent and giving back some of the bid as US equities ran to records and risk appetite improved. WTI crude trades around $101.59, back above the $100 line with the EIA flow data and Aramco's stock warning behind it. Copper retreated from its record close as Chinese physical purchases slowed — a useful tell that the metals leg of the commodity move is demand-sensitive in a way oil currently is not. The US 10-year sits near 4.47% and the 30-year cleared at a 5% auction yield, the long-end repricing that matters more this week than the front end.
• OpenAI trial, Musk's "hair-raising" demands, and the governance overhang

  The Musk–OpenAI trial moved into substance: Sam Altman testified that Musk made "hair-raising" demands for control of OpenAI, the cleanest on-record account yet of the 2018-era split that still shapes the AI competitive map. Separately, a judge said Elon Musk's settlement with the SEC raises "red flags" — two parallel legal threads keeping the Musk corporate-governance file live. On the deal tape: GameStop's Ryan Cohen is threatening to take a $56bn eBay offer directly to shareholders after eBay rejected it as "neither credible nor attractive"; Bezos's Blue Origin is weighing its first external fundraising; Delivery Hero's chief is stepping down under activist pressure; and Crispin Odey settled sexual-assault claims ahead of his London trial. Wall Street's top prosecutor pushed back on the "private credit is a cancer" framing even as Blue Owl's retail fundraising evaporated amid private-credit concerns.
• Health, AI in medicine, and the clinician's weather report

  Three threads for Luca. (1) Hantavirus moved decisively toward reassurance: Bloomberg reports the virus shows no sign of mutation and the US cruise-ship case has been cleared, while a longer feature notes Chilean scientists were close to a vaccine before funding ran out and the Covid pandemic stopped the work — the structural lesson is the funding gap, not the pathogen. Clinical framing is unchanged: high case fatality in severe HPS, very low person-to-person transmission, a surveillance story rather than a pandemic mechanism. (2) The EU plans to stockpile key drugs to avoid a repeat of pandemic-era panic buying — relevant for Italian hospital-pharmacy and procurement planning. (3) Therapeutics: Shionogi's antiviral pill prevented Covid in a household-exposure study, a meaningful prophylaxis signal worth tracking. On the policy side, FT reporting that Trump's cuts to grocery (SNAP) subsidies are biting US food companies is the public-health-nutrition shadow of the fiscal story.

Markets snapshot — live levels at the Rome open

Levels read this morning from Bloomberg's live Europe homepage ticker via Control Chrome. US cash equity values reflect Wednesday's record close carried into pre-open; oil is intra-session; Asia values are the most recent prints available and are labelled where dated.

Geopolitics & today's watch

Beijing is the centre of gravity. The Trump–Xi summit opened this morning with a deliberately warm tone — Xi's "the world is watching" and "partners not rivals," Trump's "better than ever" and his public demand that Xi open China to US business. The substance is back-loaded: economic deliverables first, the harder files (Taiwan arms, any Chinese signal on Iranian-crude purchases) likely reserved for Friday's working lunch. The structural read worth holding onto is Bloomberg's — Trump brought executives, but Xi holds the leverage, and the Iran war is consuming the US bandwidth that would otherwise go to trade and tech. The Eric Trump trip detail is the conflict-of-interest thread the FT is pursuing. Treat tomorrow's lunch as the binary moment, not today's ceremony.

The Iran file remains the operational pivot underneath the summit. Hormuz is in week twelve, the EIA has now put an official near-30% figure on the flow loss, and the escalation signals are still live — a rare Japanese tanker transit, a Chinese tanker reportedly set to test the US naval blockade, and FT reporting that Saudi Arabia launched strikes against Iran. The UAE denied the Netanyahu secret-visit story. The IEA's warning of further price spikes as inventories plunge, plus Aramco's repeated "critically low" fuel-stock line, keep the long-Brent-vol and long-refining-pain trades intact.

Two adjacent threads. First, the UK: Streeting's move from cabinet to open challenger makes this the cleanest live political event in the European session, with gilts already selling off and sterling carrying the discount — a transition still most plausibly measured in weeks, which is why the move has been orderly rather than disorderly so far. Second, Ukraine: Putin and Zelenskyy have both cooled on the US-led peace talks, undercutting Trump's earlier ceasefire claim; Zelenskyy's former chief of staff is now targeted in a major corruption probe, and Kyiv is nonetheless nearing a Pentagon deal to test drones in the US. Germany's AfD is seeing a support surge after criticising Trump's Iran war — the European-politics slow burn to track into the autumn.

Central banks & the rate-cut narrative

The US story is now a leadership story. Warsh is confirmed, Powell's term ends tomorrow, and the narrowest-ever confirmation margin is itself the market-relevant fact: the transition begins with Fed independence already politicised. The bond market priced it immediately — a 30-year auction clearing at 5% for the first time since 2007 is the long-end repricing the credibility-and-fiscal discount. The practical read for the curve is a front end still open to summer cuts against a long end carrying more term premium; the steepening bias on fiscal-and-Fed-politics headlines is the cleaner expression than any single front-end call. April retail sales and initial jobless claims this week are the data the new-chair narrative gets measured against.

Europe is the steadier picture. Lagarde framed this as a make-or-break moment to reform the EU and the ECB's Lane set out the factors that will shape the next rate move; money markets still lean toward an 11 June hike with further tightening priced through year-end. The BOJ's June-hike signal is in the price, and the strong 30-year JGB auction confirms domestic positioning is comfortable. Japan's coordination with Bessent on yen policy is the FX-stability piece that lets the BOJ move without a currency accident. UK Q1 flash GDP at 08:00 and EU March industrial production are today's European data events, both landing into a gilt market already unsettled by the leadership crisis.

Big Tech, AI & corporates

The composition story keeps sharpening. US equities hit fresh records on a tech boost; Cerebras raised $5.55bn in the year's biggest IPO after an eleventh-hour takeover attempt by Arm and SoftBank; Alphabet is issuing debt globally at a pace that left bankers scrambling to fund the AI race. But the breadth tells are the more important read: the FT notes China's big tech groups are missing the AI frenzy entirely, and Europe's handful of AI-exposed names are soaring precisely because the investable set is so thin — a market rewarding scarcity, not just demand. The Musk–OpenAI trial added on-record colour, with Altman testifying to Musk's "hair-raising" control demands, while a judge flagged "red flags" in Musk's SEC settlement. Anduril doubling to a $60bn-plus valuation is the defence-tech leg of the same capital wave.

Around the deal tape: GameStop's Ryan Cohen is threatening to take a rejected $56bn eBay offer to shareholders directly; Intertek is set to agree a £10.6bn takeover by EQT; CSG bid for a stake in KNDS, testing European defence consolidation; JPMorgan reshuffled its investment-bank leadership; Bezos's Blue Origin is weighing its first outside raise; Delivery Hero's chief is stepping down under activist pressure; Panasonic's battery unit is being boosted by expected Tesla EV gains; and BYD is touting "flash-charging" to take share from petrol cars. On private credit, Wall Street's top prosecutor rejected the "cancer" framing even as Blue Owl's retail fundraising evaporated and retail investors eyed the exits — the asset class's biggest test, per Bloomberg's framing, is now underway.

Health & science (worth a glance)

The hantavirus story moved firmly toward reassurance overnight: Bloomberg reports the virus shows no sign of mutation and the US cruise-ship case has been cleared, which removes the cross-border-transmission worry that drove the earlier headlines. A separate Bloomberg feature is the more lasting point — Chilean researchers had the building blocks of a vaccine and treatment taking shape before funding ran out and the Covid pandemic redirected resources. For Luca the teaching point this autumn is less the pathogen (clinical framing unchanged: high case fatality in severe HPS, very low person-to-person transmissibility) and more the structural fragility of vaccine pipelines that depend on continuous funding.

Two institutional reads worth flagging. First, the EU plans to stockpile key drugs to avoid a repeat of pandemic-era panic buying — a supply-chain-resilience move with direct implications for Italian hospital-pharmacy and regional procurement planning. Second, on therapeutics, Shionogi's antiviral pill prevented Covid in a household-exposure study, a prophylaxis result worth tracking for how it might reshape post-exposure protocols. On the policy-and-nutrition side, the FT's reporting that Trump's SNAP grocery-subsidy cuts are biting US food companies is the public-health shadow of the fiscal story — consumer demand dropping as households lose subsidy access, with downstream effects on food-insecurity metrics. The FT also notes EU countries have spent barely half of the €577bn Covid stimulus, a reminder that pandemic-era fiscal capacity remains largely unused.

Week ahead (CET)

• TodayThu 14 May · Trump–Xi summit day one (bilateral at the Great Hall of the People) · UK — Q1 flash GDP 08:00 · JP — Q1 flash GDP (printed overnight) · EU — March industrial production · US — initial jobless claims; April retail sales · Walmart Q1 pre-market · Applied Materials & Alibaba earnings · FT US Pharma & Biotech Summit (New York)
• Fri 15Trump–Xi summit day two (working lunch) · Powell's Fed-chair term ends · US — May Empire manufacturing · April industrial production · May U-Mich preliminary 16:00
• Mon 18Eurogroup · EU — March trade balance · NY Fed services index · China — April activity data overnight
• Sun 17FT Business of Luxury Summit opens (Borgo Egnazia, Puglia)
• WatchHormuz "week twelve and counting" · EIA −30% flow figure · oil above $100 · UK leadership timetable & gilt stress · Korea AI-tax / froth follow-through · Warsh transition tone · US 30y at 5%
• Ahead11 June ECB (June hike still leaned) · BOJ June meeting (hike signal live) · Fed 16–17 June (first meeting under the Warsh transition) · Trump–Xi commitments follow-through